Aus dem Knochenmark stammende Stammzellen bei Leberzirrhose: Klinische Beweise und regenerative Mechanismen (2026)

Zuletzt aktualisiert: August 17, 2026

Aus dem Knochenmark stammende Stammzellen bei Leberzirrhose: Klinische Beweise und regenerative Mechanismen (2026)

Meta-Beschreibung:
Wie werden aus dem Knochenmark gewonnene Stammzellen bei Leberzirrhose eingesetzt?? Entdecken Sie klinische Beweise, Mechanismen, und Ergebnisse in der regenerativen Hepatologie.

---

Einführung

Bone marrow-derived stem cells were among the first cell types investigated in regenerative therapy for liver cirrhosis and remain a foundational approach in this field.

These cells include both:

• Hämatopoetische Stammzellen (HSCs)
• Aus dem Knochenmark stammende mesenchymale Stammzellen (BM-MSCs)

Their long history of clinical use and established safety profile make them a key reference point in stem cell-based liver treatment strategies.

---

What Are Bone Marrow-Derived Stem Cells?

Frage: What types of stem cells are found in bone marrow?
Antwort:
Bone marrow contains multiple stem cell populations, primarily:

• Hämatopoetische Stammzellen → responsible for blood cell production
• Mesenchymale Stammzellen → involved in tissue repair and regeneration

These cells can be collected through bone marrow aspiration and used for therapeutic purposes.

---

Why Bone Marrow Stem Cells Are Used in Cirrhosis

Frage: What makes bone marrow a valuable source?
Antwort:

Bone marrow-derived stem cells are:

• Well-characterized and extensively studied
• Clinically validated in multiple trials
• Capable of supporting liver regeneration
• Suitable for autologous therapy

Their use represents one of the earliest successful applications of cell therapy in hepatology.

---

Wirkmechanismen bei Leberzirrhose

1. Stimulation der Hepatozytenregeneration

Bone marrow-derived cells release growth factors that promote hepatocyte proliferation and improve liver function.

---

2. Antifibrotische Wirkung

Frage: Can bone marrow stem cells reduce fibrosis?
Antwort:
Ja. These cells influence stellate cell activity and contribute to the reduction of collagen deposition, supporting fibrosis reversal.

---

3. Improvement of Liver Microenvironment

Bone marrow stem cells help restore a regenerative environment by:

• Enhancing cellular communication
• Supporting tissue repair
• Improving metabolic activity

---

4. Angiogenesis and Vascular Support

These cells promote the formation of new blood vessels, improving hepatic circulation and oxygen delivery.

---

Klinische Beweise und Studien (2025–2026)

Clinical studies involving bone marrow-derived stem cells show:

• Improvement in liver function tests
• Increased albumin levels
• Reduction in fibrosis markers
• Improvement in clinical symptoms

In einigen Fällen, patients demonstrate stabilization of cirrhosis progression.

---

Autologous vs Allogeneic Use

Frage: Are bone marrow stem cells taken from the patient or donor?
Antwort:

• Autologous therapy → cells taken from the patient, minimal rejection risk
• Allogeneic therapy → donor cells, potentially stronger regenerative effect but requires compatibility

Both approaches are used depending on clinical protocols.

---

Methoden der Verabreichung

Bone marrow-derived stem cells can be delivered through:

• Intravenöse Infusion
• Injektion in die Leberarterie
• Portal vein administration

The route of delivery can influence cell distribution and therapeutic efficacy.

---

Sicherheitsprofil

Frage: Are bone marrow stem cells safe?
Antwort:
Ja. They have one of the most established safety profiles among stem cell therapies, mit:

• Low risk of adverse events
• Gute Verträglichkeit
• Extensive clinical experience

---

Einschränkungen und Herausforderungen

Trotz ihrer Vorteile, several limitations exist:

• Invasive collection procedure
• Lower proliferation compared to umbilical cord cells
• Variable therapeutic response
• Need for optimized protocols

These factors are being addressed in ongoing research.

---

Zukünftige Richtungen

Zukünftige Entwicklungen umfassen:

• Combination therapies with MSCs and exosomes
• Gene-enhanced bone marrow-derived cells
• Improved cell expansion techniques
• Integration with precision medicine approaches

These innovations aim to enhance clinical outcomes.

---

Abschluss

Bone marrow-derived stem cells remain a cornerstone in the development of regenerative therapies for liver cirrhosis.

Their well-established clinical background, combined with ongoing innovations, ensures their continued relevance in modern hepatology.

As part of a broader regenerative strategy, these cells contribute to:

• Liver repair
• Fibrosis reduction
• Functional improvement